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RESEARCH ARTICLE Open Access
Effect of hyperchloremia on acute kidney
injury in critically ill septic patients: a
retrospective cohort study
Lenar Yessayan1*, Javier A. Neyra2,3, Fabrizio Canepa-Escaro4, George Vasquez-Rios2, Michael Heung1,
Jerry Yee5 and for the Acute Kidney Injury in Critical Illness Study Group
Abstract
Background: Hyperchloremia is common in critically ill septic patients. The impact of hyperchloremia on the
incidence of acute kidney injury (AKI) is not well studied. We investigated the association between hyperchloremia
and AKI within the first 72 h of intensive care unit (ICU) admission.
Methods: 6490 ICU adult patients admitted with severe sepsis or septic shock were screened for eligibility.
Exclusion criteria included: AKI on admission, baseline estimated glomerular filtration rate (eGFR) <15 ml/min/1.
73 m2, chronic renal replacement therapy, absent baseline serum creatinine data, and absent serum chloride data
on ICU admission.
Results: A total of 1045 patients were available for analysis following the implementation of eligibility criteria: 303
(29%) had hyperchloremia (Cl0≥ 110 mEq/L) on ICU admission, 561 (54%) were normochloremic (Cl0 101–109 mEq/L)
and 181 (17%) were hypochloremic (Cl0≤ 100 mEq/L). AKI within the first 72 h of ICU stay was the dependent variable.
Chloride on ICU admission (Cl0) and change in Cl by 72 h (ΔCl = Cl72 – Cl0) were the independent variables. The odds
for AKI were not different in the hyperchloremic group when compared to the normochloremic group [adjusted odds
ratio (OR) =0.80, 95% confidence interval [CI] (0.51–1.25); p = 0.33] after adjusting for demographics, comorbidities,
baseline kidney function, drug exposure and critical illness indicators including cumulative fluid balance and base
deficit. Furthermore, within the subgroup of patients with hyperchloremia on ICU admission, neither Cl0 nor ΔCl was
associated with AKI or with moderate/severe AKI (KDIGO Stage ≥2).
Conclusions: Hyperchloremia occurs commonly among critically ill septic patients admitted to the ICU, but does not
appear to be associated with an increased risk for AKI within the first 72 h of admission.
Keywords: Hyperchloremia, Sepsis, Acute kidney injury, Chloride load
Background
Chloride is the most abundant anion in the extracellular
fluid and the second most important contributor to
plasma tonicity [1]. It plays an essential role in many
body functions including acid-base balance, muscular ac-
tivity, osmosis, and immunomodulation [2]. The possi-
bility of harm from hyperchloremia, particularly in the
context of fluid resuscitation with chloride-liberal solu-
tions, has recently garnered the research interest of the
scientific community. Recent observational studies have
shown increased mortality with chloride rich solutions,
[3] chloride load, [4] and hyperchloremia [5, 6]. Animal
and human experiments have also suggested that
chloride-rich solutions may have a detrimental effect on
renal function [7–11]. Proposed explanations of this
association include renal vasoconstriction leading to
reduction in renal cortical tissue perfusion and renal
interstitial edema leading to intracapsular hypertension
[7–9]. However, a recent large cluster randomized trial
in a heterogeneous population of patients did not dem-
onstrate a difference in the risk of acute kidney injury
(AKI) or mortality among those who received buffered
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crystalloids compared with 0.9% saline [12]. Criticism of
this trial includes the lack of data delineating phenotypic
characteristics between the two groups such as serum
chloride data, the minimal total exposure to these two
types of fluid, and the overall low incidence of AKI in
the study population.
Therefore we aimed to investigate the association of
hyperchloremia on intensive care unit (ICU) admission
and the development of AKI within 72 h in critically ill
patients with severe sepsis or septic shock, a group of
patients with high risk for AKI. We also aimed to inves-
tigate whether AKI incidence varied by admission serum
chloride level or by serum chloride level changes in the
first 72 h in patients who were hyperchloremic on ICU
admission. Our hypothesis was that high chloride levels
would be associated with the occurrence of AKI.
Methods
Study design and participants
We conducted a single-center, retrospective cohort
study utilizing a population-based, ICU database of adult
patients with severe sepsis or septic shock admitted to
Henry Ford Hospital, an urban, tertiary care hospital
from May 2007 through April 2012. Severe sepsis or
septic shock was defined by Angus criteria [13], using
the International Classification of Diseases, Ninth Revi-
sion, Clinical Modification (ICD-9-CM) codes [14] for a
bacterial or fungal infection and a diagnosis of acute
organ dysfunction excluding gastrointestinal failure.
Exclusion criteria included the presence of any of the
following: absent serum creatinine (SCr) measurement
within 3 months prior to ICU admission; baseline esti-
mated glomerular filtration rate (eGFR) < 15 ml/min/
1.73 m2 using the 4-variable Modification of Diet in
Renal Disease study eq. [15]; patients on chronic renal
replacement therapy; patients with AKI or absent serum
chloride data on ICU admission; and those with absent
recorded daily fluid balance within the first 72 h of ICU
stay. Data were electronically extracted from electronic
health record (EHR) by data management personnel
blinded to the study. The accuracy of data collection was
further validated by individual EHR review of 10% of the
data. The protocol was approved by the institutional re-
view board of Henry Ford Hospital (IRB #7044).
Study variables
Serum chloride was measured by indirect potentiometry
(SYNCHRON Systems, Beckman Coulter Inc., Brea,
CA). The delta chloride (ΔCl) was defined as the differ-
ence between serum chloride at 72 h (Cl72) and serum
chloride on ICU admission (Cl0). The Acute Physiology
and Chronic Health Evaluation II (APACHE II) and Se-
quential Organ Failure Assessment (SOFA) scores were
calculated after integration of clinical and laboratory
data within the first day of ICU admission. Cumulative
fluid balance was calculated based on total fluid input
minus output within the first 72 h of ICU stay. These
data did not include pre-ICU fluid administration. Base
deficit was calculated by subtracting the serum HCO3
−
measurement on ICU admission from the normal serum
HCO3
− value of 24 mEq/L. Subject-specific variables were
obtained from EHRs. Comorbidities (e.g., diabetes, hyper-
tension, and heart failure) were identified using ICD-9-
CM codes, except for anemia that was defined as admis-
sion hematocrit <39% for men and <36% for women. Data
pertaining to drug exposure, red blood cell transfusion,
and mechanical ventilation were based on hospital billing
codes for the indexed admission within the time frame of
the study.
Study outcomes
The primary outcome measure was the occurrence of
any AKI (KDIGO Stage ≥1), or moderate/severe AKI
(KDIGO Stage ≥2) within the first 72 h of ICU stay and
was adjudicated based on Kidney Disease Improving
Global Outcomes consensus SCr-based criteria by com-
paring the highest SCr measured within the first 72 h of
ICU admission and the reference SCr within 3 months
before admission [16].
Statistical analysis
The study sample was divided into 3 subgroups based
on serum chloride (Cl) levels at the time of ICU admis-
sion: hyperchloremia (Cl0 ≥ 110 mEq/L), normochlore-
mia (Cl0 101–109 mEq/L) and hypochloremia (Cl0 ≤
100 mEq/L). Categorical data were reported as percent-
ages and continuous data as means ± standard deviation
or median (25th – 75th percentile). For categorical vari-
able comparison between the three subgroups, the chi-
square test was used. Analysis of variance (ANOVA) was
used for continuous variable comparisons when data
were normally distributed and the Kruskal-Wallis test
was used for non-normally distributed data.
The associations between AKI (any AKI or moderate/
severe AKI) within 72 h (dependent variable) and 1)
serum chloride subgroups on ICU admission and 2) ad-
mission serum chloride levels (Cl0) within the hyper-
chloremic subgroup and 3) delta serum chloride at 72 h
(ΔCl = Cl72 – Cl0) within the hyperchloremic subgroup
were examined using multivariable logistic regression
models. These associations were also tested within the
hypochloremic subgroup. For the three chloride subgroup
comparison in the incidence of AKI, a multivariable logis-
tic regression model was used. The model was adjusted
for confounders that were unequally distributed between
the three subgroups (p-value for comparison <0.25 in
Table 1). To further test whether worsening hyperchlore-
mia is associated with AKI in the hyperchloremic
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subgroup, we evaluated the association of serum chloride
on ICU admission (Cl0) and delta chloride (ΔCl = Cl72 –
Cl0) with the incidence of AKI within 72 h in this sub-
group. The multivariable logistic models included all vari-
ables with P-value of <0.25 in univariate models of AKI.
Candidate variables included demographic data (age, gen-
der, and race); comorbidity (baseline eGFR, diabetes,
hypertension, heart failure, and anemia); indicators of crit-
ical illness (oliguria, APACHE II, SOFA, cumulative fluid
balance, base deficit, mechanical ventilation, red blood cell
transfusion); and drug exposure (diuretic, statin, amino-
glycoside, and intravenous or intra-arterial iodine con-
trast). Only 1 of 2 variables was included in the event of
collinearity between variables. The 95% CIs reported for
the logistic regression odds ratios (ORs) were calculated
by the Wald estimation. Two-sided P-values <0.05 indi-
cated statistical significance. Spreadsheet software and
SAS 9.3 (SAS Institute, Cary, NC) were used for data ac-
quisition and analysis.
Results
Of 6490 patients examined for eligibility, 1045 satisfied
inclusion and exclusion criteria (Fig. 1). Age was 66.0 ±
16.1 years, 360 (34.5%) were African Americans, 479
(45.8%) were male. A total of 482 (46.1%) patients were
either on vasopressors or inotropes and 315 (30.1%)
were on diuretics. The median cumulative fluid balance
in the first 72 h of ICU stay was 2063 ml [25th – 75th
percentile, −678 to 6029 ml]. The mean SOFA score was
4.9 ± 3.6 and APACHE II score was 12.9 ± 6.2. The mean
Table 1 Clinical characteristics stratified by 3 serum chloride subgroups at the time of ICU admission: Hyperchloremia (Cl0≥
110 mEq/L); Normochloremia, (Cl0 100–109 mEq/L); and Hypochloremia (Cl0 ≤ 100 mEq/L)
Variable Admission Serum
Chloride (Cl0)
≥110 mEq/L
(n = 303)
Admission Serum
Chloride (Cl0)
101–109 mEq/L
(n = 561)
Admission Serum
Chloride (Cl0)
≤100 mEq/L
(n = 181)
P-value
Demographics
Age, years, mean ± SD 67.9 ± 15.6 64.8 ± 16.7 67.0 ± 14.6 0.0146*
Male, % 44.9% 53.7% 55.8% 0.0214*
African-American, % 42.6% 33.2% 24.9% 0.0002*
Chronic conditions
Baseline SCr, mg/dl, median (IQR) 1.2 (0.9–1.7) 1.2 (0.9–1.6) 1.2 (0.9–1.6) 0.0794
Baseline eGFR, mL/min/1.73m2, median (IQR) 57.0 (40.4–76.8) 63.1 (44.2–87.9) 61.2 (42.1–88.0) 0.1032
Diabetes, % 23.8% 20.1% 21.6% 0.4648
Hypertension, % 46.5% 46.5% 43.7% 0.8050
Heart failure, % 3.3% 2.1% 4.4% 0.2423
Anemia, % 88.6% 85.1% 74.4% 0.0001*
Drug Exposure
Diuretic, % 44.2% 44.0% 55.8% 0.0161*
Statin, % 28.7% 30.8% 30.4% 0.8073
Iodine contrast, % 27.7% 33.9% 29.3% 0.1446
Aminoglycoside, % 8.3% 6.1% 1.7% 0.0119*
Critical indicators
Oliguria, % 9.0% 6.2% 5.3% 0.2467
CFB 72 h, liters, median (IQR) 3.1 (−0.1–8.0) 2.0 (−0.5–5.4) 0.75 (−2.1–3.8) 0.0005*
Pressor or inotrope, % 37.3% 30.1% 27.6% 0.0408*
Mechanical ventilation, % 51.2% 39.4% 33.2% <0.0001*
Red blood cell transfusion, % 6.6% 2.0% 0.6% <0.0001*
Base Deficit, mmol/L
Median (IQR)
3.6 (1.7–6.4) 1.1 (−1.7–4.0) −2.6 (−7.4–2.4) <0.0001
APACHE II score, mean ± SD 14.9 ± 7.0 12.1 ± 5.9 11.80 ± 5.06* <0.0001
SOFA score, mean ± SD 5.8 ± 3.8 4.5 ± 3.4 4.4 ± 3.4* <0.0001
*eGFR = estimated glomerular filtration rate based on Modification of Diet in Renal Disease (MDRD) Study equation; SCr = serum creatinine; iodine contrast only if
intravenous or intra-arterial; CFB = cumulative fluid balance; oliguria defined as urine output less than 500 ml in 24 h; anemia = admission hematocrit <39% for
men and <36% for women; APACHE II = Acute Physiology and Chronic Health Evaluation II; SOFA = Sequential Organ Failure Assessment
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base deficit was 1.9 ± 7.0 mEq/L. Serum chloride on ICU
admission was 106 ± 7 mEq/L (range 82–130 mEq/L)
and 237 (22.7%) of patients developed AKI within the
first 72 h of ICU stay.
Of the 1045 patients that satisfied eligibility criteria,
303 (29.0%) were hyperchloremic (Cl0 ≥ 110 mEq/L) on
ICU admission, 561 (53.7%) were normochloremic (Cl0
101–109 mEq/L) and 181 (17.3%) were hypochloremic
(Cl0 ≤ 100 mEq/L). Baseline characteristics by admission
chloride subgroup are shown in Table 1. The following
variables were unequally distributed between the three
serum chloride subgroups: age, gender, race, anemia, heart
failure, aminoglycoside use, diuretic administration, intra-
venous or intra-arterial iodine exposure, pressor or ino-
trope use, cumulative fluid balance, % weight gain,
mechanical ventilation, red blood cell transfusion, base
deficit, oliguria and indices of critical illness severity
(APACHE II and SOFA scores). A multivariable logistic
regression model adjusted for the aforementioned vari-
ables did not show any difference in the odds for any AKI
in the hyperchloremic group when compared to the nor-
mochloremic group [adjusted odds ratio = 0.80, 95% confi-
dence interval [CI] (0.51–1.25); p = 0.33] and lower odds
for AKI when compared to the hypochloremic group [ad-
justed OR = 0.50, 95% CI (0.28–0.91); p = 0.03]. The odds
for moderate/severe AKI in the hyperchloremic group
were not different from the normochloremic group [ad-
justed odds ratio = 0.97, 95% CI (0.50–1.91); p = 0.93] or
the hypochloremic group [adjusted OR = 0.42, 95% CI
(0.18–1.01); p = 0.05].
The independent association of both serum chloride
levels on admission (Cl0) and delta chloride (ΔCl) with
AKI at 72 h was assessed in multivariable models within
the hyperchloremic subgroup. All variables with P values
of <0.25 from the univariate analyses were included in
the multivariate analyses. Serum chloride level on admis-
sion (Cl0) was not associated with the occurrence of AKI
at 72 h [adjusted odds ratio per 1 mEq/L increase in Cl0
= 0.99, 95% CI (0.89–1.09); p = 0.81] or moderate/severe
AKI at 72 h [adjusted odds ratio per 1 mEq/L increase
in Cl0 = 0.95, 95% CI (0.81–1.11); p = 0.52] (Table 2).
Furthermore, within-subject change in serum chloride
(ΔCl) during the first 72 h of ICU stay was also not asso-
ciated with either AKI at 72 h [adjusted odds ratio per
1 mEq/L increase in ΔCl =1.04, 95% CI (0.97–1.11); p =
0.27] or moderate/severe AKI at 72 h [adjusted odds ra-
tio per 1 mEq/L increase in ΔCl =1.03, 95% CI (0.93–
1.14); p = 0. 0.62] (Table 3).
In the hypochloremic subgroup, and using the same
multivariable models, there was no independent associ-
ation between the occurrence of AKI at 72 h and either
serum chloride levels on admission (Cl0) [adjusted odds
ratio per 1 mEq/L decrease in Cl0 = 1.02, 95% CI (0.91–
1.15); p = 0.67] or delta chloride (ΔCl) [adjusted odds ra-
tio per 1 mEq/L decrease in ΔCl =1.18, 95% CI (0.41–
3.40); p = 0.66].
Discussion
In this large retrospective cohort study of critically ill
septic patients, we did not find an association between
Fig. 1 Flowchart of Patient Inclusion and Reasons for Exclusion. CFB = cumulative fluid balance; Cl0 = serum chloride at the time of ICU admission;
eGFR = estimated glomerular filtration rate; ICU = intensive care unit; SCr = serum creatinine; AKI = Acute kidney injury
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Table 2 Univariable analyses of determinants of any AKI and multivariable analyses investigating the association between chloride
levels on ICU admission and 1) any AKI at 72 h and 2) moderate/severe AKI at 72 h
Variable Any AKI Any AKI
Hyperchloremic Subgroup
Moderate/Severe AKI
Hyperchloremic Subgroup
Odds Ratio
Univariable
P-value Odds Ratio
Multivariable
P-value Odds Ratio
Multivariable
P-value
Cl0
per mEq/L increase
1.01
(0.94–1.09)
0.7317 0.99
(0.89–1.09)
0.8072 0.95
(0. 81–1.11)
0.5200
Age, years 1.00
(0.98–1.01)
0.5412 – – – –
Male 1.65
(0.95–2.87)
0.0774 1.72
(0.80–3.69)
0.1625 3.03
(0.89–10.29)
0.0750
African-American 1.25
(0.72–2.17)
0.4338 – – – –
Baseline eGFR
per mL/min/1.73m2
1.00
(0.99–1.01)
0.9957 – – – –
Diabetes 0.61
(0.30–1.23)
0.1672 0.54
(0.22–1.35)
0.1874 0.75
(0.22–2.61)
0.6514
Hypertension 0.63
(0.36–1.10)
0.1045 0.753
(0.37–1.54)
0.4370 1.02
(0.36–2.93)
0.9655
Heart failure 3.97
(1.11–14.15)
0.0338 3.86
(0.93–16.06)
0.0633 1.90
(0.22–16.62)
0.5640
Anemia 1.26
(0.50–3.18)
0.6305 – – – –
Diuretic 2.37
(1.34–4.16)
0.0028 2.631
(1.21–5.74)
0.0150 1.75
(0.56–5.45)
0.3362
Statin 0.64
(0.33–1.22)
0.1760 0.47
(0.21–1.07)
0.0728 1.00
(0.31–3.22)
0.9996
Iodine contrast 1.24
(0.68–2.27)
0.4783 – – – –
Aminoglycoside 1.20
(0.46–3.14)
0.7131 – – – –
Oliguria 5.35
(2.25–12.72)
0.0002 3.54
(1.20–10.46)
0.0223 10.77
(2.84–40.85)
0.0005
CFB 72 h
per 100 ml increase
1.00
(1.00–1.02)
0.0342 1.00
(1.00–1.01)
0.1772 1.05
(1.00–1.01)
0.0910
Pressor or inotrope 2.49
(1.42–4.37)
0.0014 1.28
(0.53–3.05)
0.5839 1.77
(0.45–6.87)
0.4122
Mechanical ventilation 1.96
(1.11–3.46)
0.0212 0.84
(0.34–2.03)
0.6944 0.72
(0.19–2.76)
0.6359
Red blood cell transfusion 0.64
(0.18–2.26)
0.4908 – – – –
Base Deficit
per mEq/L increase
1.03
(0.98–1.09)
0.2254 1.06
0.99–1.14
0.1211 1.10
(1.00–1.20)
0.0512
APACHE II score, per unit increase 1.05
(1.01–1.09)
0.0231 – – – –
SOFA score
per unit increase
1.19
(1.11–1.29)
<.0001 1.12
(0.99–1.27)
0.0772 1.06
(0.88–1.27)
0.5502
*eGFR = estimated glomerular filtration rate based on Modification of Diet in Renal Disease (MDRD) Study equation; SCr = serum creatinine; iodine contrast only if
intravenous or intra-arterial; CFB = cumulative fluid balance; oliguria defined as urine output less than 500 ml in 24 h; anemia = admission hematocrit <39% for
men and <36% for women; APACHE II = Acute Physiology and Chronic Health Evaluation II; SOFA = Sequential Organ Failure Assessment. Any AKI, KDIGO Stage ≥1
SCr-based; Moderate/severe AKI, KDIGO Stage ≥2 SCr-based
The univariate logistic regression analyses are investigating 20 variables as potential predictors of AKI. The two multivariate models are investigating the
association between chloride levels on admission (Cl0) and 1) any AKI at 72 h and 2) moderate/severe AKI at 72 h in the hyperchloremic subgroup. Both models
are adjusted for variables with P-value <0.25 on univariate analysis. Variables included for confounding adjustment in the final model are gender, diabetes,
hypertension, heart failure, diuretics, statins, oliguria, cumulative fluid balance, pressor or inotrope, mechanical ventilation, base deficit and Sequential Organ
Failure Assessment (SOFA) score. Acute Physiology and Chronic Health Evaluation II (APACHE II) was not included in either multivariable model because of
collinearity with SOFA score
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admission hyperchloremia (Cl0 ≥ 110 mEq/L) and AKI
within 72 h of ICU stay. We also could not detect an as-
sociation between higher serum chloride levels on ad-
mission or worsening serum chloride levels in the first
72 h and AKI among those patients with hyperchloremia
at the time of ICU admission. The latter finding further
supports the absence of any appreciable detrimental ef-
fect of hyperchloremia on kidney function in patients
with severe sepsis or septic shock.
Hyperchloremia is prevalent in the ICU, afflicting
nearly up to a third of the ICU population in some
reports [6, 17]. Over the past few years there has
been an increasing focus on the potential impact of
chloride load in resuscitation fluid and serum chlor-
ide on outcomes in critically ill patients. Several
large observational studies have associated chloride-
rich crystalloid solutions, chloride load and hyper-
chloremia with increased hospital mortality and/or
with AKI [3–6, 10, 11, 17, 18].
In a large retrospective study, Sen et al. found an asso-
ciation between total chloride load and all-cause mortal-
ity in 4710 critically ill non-surgical patients who
received at least 60 mL/kg fluid resuscitation within a
24 h period [18]. However, this association did not per-
sist after adjusting for age, volume of administered fluid
and baseline severity of illness. Shaw et al. conducted a
retrospective study to examine the effect of chloride load
among 109,836 patients with systemic inflammatory
response and demonstrated an association between
higher intravenous chloride loads and hospital mortality
[4]. Raghunathan et al. examined non-surgical critically
ill patients with sepsis and, using propensity-matching
(n = 6730), reported an association between the use of
chloride-rich solutions and increased risk for hospital
mortality but not AKI [3]. We previously showed an
association between worsening hyperchloremia and
hospital mortality in critically ill septic patients admitted
with hyperchloremia [6]. Similarly, a single center
Table 3 Multivariable analyses investigating the association between delta chloride (Δ Cl) from admission to 72 h post-admission
and 1) any AKI at 72 h and 2) moderate/severe AKI at 72 h
Variable Any AKI
Hyperchloremic Subgroup
Moderate/Severe AKI
Hyperchloremic Subgroup
Odds Ratio
Multivariable
P-value Odds Ratio
Multivariable
P-value
ΔCl
per mEq/L increase
1.04
(0.97–1.11)
0.2652 1.03
(0.93–1.14)
0.6164
Male 1.49
(0.60–3.70)
0.3948 6.38
(1.16–34.99)
0.0329
Diabetes 0.55
(0.20–1.50)
0.2449 0.88
(0.21–3.73)
0.8645
Hypertension 0.60
(0.26–1.36)
0.2196 0.55
(0.15–1.95)
0.3545
Heart failure 7.06
(1.33–37.52)
0.0219 2.54
(0.15–43.62)
0.5205
Diuretic 3.35
(1.26–8.91)
0.0156 3.61
(0.74–17.60)
0.1118
Statin 0.51
(0.20–1.30)
0.1564 1.12
(0.26–4.83)
0.8795
Oliguria 6.09
(1.66–22.39)
0.0066 33.05
(4.89–223.45)
0.0003
CFB 72 h
per 100 ml increase
1.00
(1.00–1.01)
0.4866 1.01
(1.00–1.02)
0.1821
Pressor or inotrope 1.37
(0.51–3.69)
0.5277 1.66
(0.35–8.01)
0.5255
Mechanical ventilation 1.10
(0.36–3.32)
0.8734 1.46
(0.26–8.37)
0.6703
Base Deficit
per mEq/L increase
1.05
(0.96–1.15)
0.2777 1.12
(0.96–1.30)
0.1411
SOFA score
per unit increase
1.09
(0.95–1.25)
0.2340 0.98
(0.80–1.20)
0.8472
CFB = cumulative fluid balance; oliguria defined as urine output less than 500 ml in 24 h; anemia = admission hematocrit <39% for men and <36% for women;;
SOFA = Sequential Organ Failure Assessment; Any AKI, KDIGO Stage ≥1 SCr-based; Moderate/severe AKI, KDIGO Stage ≥2 SCr-based
The two multivariate models are investigating the association between delta chloride at 72 h (ΔCl = Cl72 – Cl0) and 1) any AKI at 72 h and 2) moderate/severe AKI
at 72 h in the hyperchloremic subgroup. Both models are adjusted for variables with P-value <0.25 on univariate analysis reported in Table 2
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prospective study by Boniatti et al. showed that hyper-
chloremia was associated with hospital mortality.
Although serum chloride was not a good predictor of
hospital mortality, a clinical model that included albu-
min, age, SOFA score, in addition to serum chloride pro-
vided a good discriminatory ability to predict mortality
(area under the receiver operating curve for this model
was 0.80 [95% confidence interval, 0.73–0.87]) [5].
Zhang et al. showed that patients with AKI have higher
maximum chloride levels than patients who did not de-
velop AKI in a group of medical, surgical and post-
cardiac surgery patients. A distinctive difference with
our study is that they did not adjust for disease severity
scores such as SOFA or APACHE-II, and the serum
chloride levels (predictor) were not examined at contem-
poraneous time points in reference to the occurrence of
AKI [11]. We selected AKI within 72 h of ICU admis-
sion as the main outcome of our study to adjust for crit-
ical clinical parameters during this time period (i.e.,
SOFA score and cumulative fluid balance) that may con-
found the relationship between serum chloride levels
and AKI.
Proposed explanations of renal damage by chloride-
rich solutions include dysregulated tubuloglomerular
feedback activated by chloride reaching the macula
densa and causing renal afferent arteriole vasoconstric-
tion leading to a reduction in renal cortical tissue perfu-
sion and consequent tissue ischemia. An alternative
mechanism is through fluid overload and renal intersti-
tial edema leading to intracapsular hypertension or vaso-
motor nephropathy [7, 9, 19].
Observational studies have shown an association be-
tween chloride- rich solutions and AKI. Yunos and col-
leagues, in a large prospective study of quasi-experimental
design (1533 patients), reported a lower incidence of AKI
when a chloride-restrictive fluid strategy was implemented
in the ICU (8.4% versus 14.0%, p < 0.001) [10]. A distinct-
ive difference with our study is that they did not adjust for
disease severity scores such as SOFA or APACHE-II, and
the serum chloride levels (predictor) were not examined
at contemporaneous time points in reference to the occur-
rence of AKI [11]. We selected AKI within 72 h of ICU
admission as the main outcome of our study to adjust for
critical clinical parameters during this time period (i.e.,
SOFA score and cumulative fluid balance) that may con-
found the relationship between serum chloride levels and
AKI. A recent meta-analysis of 21 studies (6253 patients)
found that administration of chloride-rich fluids was asso-
ciated with increased risk for hyperchloremic acidosis and
AKI but not mortality [20].
The association of chloride-rich solutions with AKI
was not observed in two recent controlled trials. The
SPLIT trial, a major trial of buffered crystalloids versus
0.9% saline among 2278 ICU patients, found no
difference in the incidence of AKI or rates of renal re-
placement therapy between the two strategies [12]. Simi-
larly, the LICRA pragmatic trial, a study comparing
perioperative chloride-poor intravenous fluids to
chloride-rich intravenous fluids among 1136 patients,
did not show a difference in the incidence of AKI after
adult cardiothoracic surgery [21]. Similar to the SPLIT
trial, our study was conducted in ICU patients and our
results are consistent with the SPLIT trial and address
some of the reported concerns with the results of the
former study, namely the low risk for AKI in their study
population (about 9%), the lack of serum chloride data
and the small overall total fluid that was administered.
In our cohort, the incidence of AKI was 22.7% and
serum chloride data on admission was available in 1045
patients. The high frequency of events in our large co-
hort allowed for multiple adjustments for confounders
without overfitting the models.
An inherent limitation to the observational studies
linking a biochemical parameter to AKI is the incapabil-
ity to entirely control for residual confounding. Beyond
the observed associations, could there be a biologic ex-
planation linking chloride administration or hyperchlor-
emia to AKI? Augmented pro-inflammatory response
[22] and diminished coagulation ability [23] have been
observed in hyperchloremic metabolic acidosis and renal
vasoconstriction may exist with higher chloride load or
hyperchloremia but the clinical significance of these
findings as a cause of AKI is uncertain.
The strengths of our study are its large sample size;
the careful selection of a representative sample of pa-
tients with severe sepsis or septic shock admitted to the
ICU; and the multivariable adjustment for clinical con-
founders directly linked to AKI including cumulative
fluid balance and comprehensive critical illness severity
scores. Limitations of our study include the absence of
data pertaining to the amount of fluid administered be-
fore ICU admission, the lack of data pertaining to the
type of fluid and the lack of timed urine output mea-
surements for AKI diagnosis. Our study population only
included patients with severe sepsis or septic shock with
an overall high risk to develop AKI. Our findings do not
preclude the possibility of harmful renal effects with
higher chloride load or hyperchloremia in other popula-
tions or in higher-risk groups. Furthermore, because our
analytical horizon was only for 72 h, we cannot com-
pletely rule out the possibility of delayed harmful renal
effects from hyperchloremia.
Conclusions
In conclusion, our study did not show an association be-
tween hyperchloremia and the incidence of AKI within
the first 72 h of ICU stay in critically ill septic patients. It
is conceivable that the administration of chloride rich
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solutions itself, rather than any resulting hyperchloremia,
is what confers the risk of AKI. It is also plausible that
there is no causal relationship between hyperchloremia or
exposure to high chloride solutions and AKI in this popu-
lation. In the absence of clinical trials showing definite evi-
dence of lack of harm with higher chloride loads, it is
probably prudent to minimize chloride load when large
amounts of crystalloids have already been administered or
when patients are already hyperchloremic. Future ran-
domized control trials evaluating the effect of buffered so-
lutions on AKI should include data pertaining to serum
chloride levels during the study period.
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